Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Heterogeneous nuclear ribonucleoprotein A1 pseudogene 14 (HNRNPA1P14) is annotated as a pseudogene of the heterogeneous nuclear ribonucleoprotein A1 (HNRNPA1) gene. Pseudogenes are genomic elements that resemble genes but are generally non-functional because of accumulated mutations, lack of regulatory elements, or other disabling changes. HNRNPA1P14 does not code for a functional protein product and is not described as a receptor, enzyme, transporter, or other conventional therapeutic target. There is no evidence that it is actionable as a target in drug discovery or disease therapy. Thus, HNRNPA1P14 itself does not participate in the canonical biological functions, disease processes, or drug interactions associated with functional proteins. No roles in diagnosis, prognosis, or prediction have been attributed to this pseudogene.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Heterogeneous nuclear ribonucleoprotein A1 pseudogene 14 (HNRNPA1P14).